Political and Public-Legal Subjectivity of Urban Agglomerations

Autor: Revekka M. Vulfovich, Victor F. Mayboroda

Publikováno v: RUDN Journal of Political Science, Vol 25, Iss 3, Pp 539-552 (2023)

Due to the gigantic scale of Russia’s territory, the problem of the settlement system and urban agglomerations as its primary development centres is urgent. The purpose of this research is to identify opportunities and limitations, both legal and o

Externí odkaz: https://doaj.org/article/86a74b93549d4320a63a5ccb5d8593fb

The Problem of Defining Local Self-Government as a Key Actor of a Unified System of Public Power and Admininstration (Analysis of the Problem Field)

Autor: R. M. Vulfovich

Publikováno v: Управленческое консультирование, Vol 0, Iss 12, Pp 17-32 (2022)

The analysis of the problem field is a serious problem from the methodological and methodical point of view. The solution of this problem becomes particularly difficult in cases when the object under study is characterized by a high level of structur

Externí odkaz: https://doaj.org/article/0ce77a74088b4ab1945981d87e07e9fa

Use Possibilities of 'Diverse Democracy' Forms under Modern Russia Conditions: Constitutional Principles and Political Reality

Autor: R. M. Vulfovich

Publikováno v: Теоретическая и прикладная юриспруденция, Vol 0, Iss 1, Pp 10-17 (2020)

In the 21st century the place and role of different social institutions changes essential. An independent and self-sufficient person becomes in a greater measure a political actor and demands the participation right enlargement not only in public act

Externí odkaz: https://doaj.org/article/4090c523ab7d472e93d50a8d9b7290ff

Administrative Reforms in Post-Soviet Russia: Principal Problems and Results

Autor: R. M. Vulfovich

Publikováno v: Управленческое консультирование, Vol 0, Iss 12, Pp 102-110 (2018)

The article is devoted to the analyses of main problems and results of administrative reforms in Russia during the transition period (since 1985) from the Soviet administrative system to the actual administrative structure. The basis for it is the mo

Externí odkaz: https://doaj.org/article/1cdd80bc636940baac9545d582966f49

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): A randomised, double-blind, placebo-controlled, phase 3 trial

Autor: David G. Mutch, J I Weberpals, Roberto Sabbatini, D K Armstrong, Susana Banerjee, Domenica Lorusso, Giovanni Scambia, Gottfried E. Konecny, Jonathan A. Ledermann, A Leary, T Neunhöffer, Hani Gabra, J C Goh, G Kichenadasse, R W Holloway, Iris L. Romero, Jesus Garcia-Donas, Martin Buck, Michael Friedlander, Nicoletta Colombo, Robert L. Coleman, Deborah K. Armstrong, Amnon Amit, E M Guerra, Stephen Welch, Salomon M. Stemmer, T Vanderkwaak, C Hänle, Ignace Vergote, Alain Lortholary, Laurence Gladieff, David M. O'Malley, J Garcia-Donas, A Clamp, James Sun, Andrew R Clamp, Mitch Raponi, Laurie Elit, Claudio Zamagni, R T Morris, A Casado Herraez, Y Drew, Benoit You, Thomas Harding, M Vulfovich, L Ma, B M Slomovitz, S Kovel, A Dean, C Aghajanian, Prafull Ghatage, A O'Donnell, L-m Chen, Diane Provencher, G Scambia, D M O'Malley, A El-Balat, Jeffrey C. Goh, M Leviov, Florence Joly, Ronnie Shapira-Frommer, Olivier Tredan, Marie Plante, Stefano Tamberi, Amit M. Oza, Kevin K. Lin, G E Konecny, E M Swisher, A Oaknin, I A McNeish, Johanne I Weberpals, Clare L. Scott, M Amenedo Gancedo, Paul R. Harnett, Mark A. Morgan, A Floquet, Jean-Pierre Lotz, Terri Cameron, Ana Oaknin, Elizabeth M. Swisher, Michael J. Birrer, Setsuko K. Chambers, Peter C.C. Fong, Andrew Dean, Carol Aghajanian, Sandro Pignata, Melanie E Powell, Alessandra Bologna, Caroline Grace, Christine Parkinson, C L Scott, Jeff Isaacson, J. Medioni, Heidi Giordano, Tamar Safra, H Denys, I Palacio, P C Fong, Margarita Amenedo Gancedo, Robert W Holloway, P Krabisch, N Colombo, Mary K. Buss, Alexandra Leary, Pauline Wimberger, A Sanchez, Luc Dirix, Sandra Goble, M Pölcher, Lara Maloney, Anne Floquet, D Jackson, Iain A. McNeish

Publikováno v: Lancet (London, England), vol 390, iss 10106

Background: \ud \ud Rucaparib, a poly(ADP-ribose) polymerase inhibitor, has anticancer activity in recurrent ovarian carcinoma harbouring a BRCA mutation or high percentage of genome-wide loss of heterozygosity. In this trial we assessed rucaparib ve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0275ed6179ab07f49e1cdef255c13c2
http://hdl.handle.net/10281/171093